DIABETES IN CHILDREN

Diabetes in children is becoming more common. Treatment of diabetes is difficult for the child, because it requires discipline. Diabetes in children: what do they threaten?

In the most severe case, damage to the central nervous system, which is due to” hypoxia ” of the brain. People who have experienced such an episode are able to see and interpret the symptoms that preceded them: sweating, nervousness, lack of concentration, hunger, and sometimes psychotic symptoms. Unfortunately, they do not always appear and then without warning there is a deep disturbance of consciousness, loss of consciousness, convulsions. That’s all children with diabetes have to learn. They have a long way to go with the disease.

diabetes-in-children

The child does not have such a sense of responsibility that would stand guard over proper therapy, which, moreover, lasts 24 hours a day. Therefore, he needs support, someone who watches over him and teaches him to make decisions in seemingly trivial matters: when to eat, when to give and when to increase the dose of inspina. It is necessary to interact with the school and quickly communicate with the house.

Type 1 diabetes poses a challenge to the education of both children and caregivers.
Diabetes affects both small children, one-year-olds, as well as preschoolers, students and rebellious teenagers. Each need to reach in a different form, another to look for motivation. And this is not easy, especially since the child, unable to cope, begins to run away from reality. There are lies and deceit in reading the results, taking meals.

Education must be continuous

They are not due to the bad character of young patients, but are a manifestation of their helplessness in the face of the demands of this difficult disease. Education must be continuous, repetitive, “tailored” to the patient and his capabilities.

How to reconcile this with the acute rigors that the disease imposes on diabetics? To what extent does modern therapy help to bear this burden?

Progress in the treatment of diabetes is enormous. The research focuses on the search for ever better clinical and pharmacological solutions in an effort to mimic the physiological release of inspin. The production of highly purified human inspins and the development of modern methods of their administration – inspin pumps and foams-are milestones in the improvement of treatment methods. Another very important achievement was the introduction of analogues of human inspina.

They are products very similar to inspina, obtained by biotechnology. They differ from human inspine by one or more amino acids. This caused a change in the properties associated mainly with their absorption from the subcutaneous tissue into the blood. The consequence of this is the acceleration of action (fast-acting analogs) or its uniform elongation (long-acting analogs), while their effect on the cells of the organism, once they get there, is practically the same as that of human inspiration.

What benefits does this have for the patient?

what-benefits-does-this-have-for-the-patient

What benefits does this have for the patient, especially the child with diabetes? Analogues, by generally better ensuring the equalization of diabetes, significantly improve the quality of life, since they allow you to reduce or change the number of meals. It becomes possible to eliminate the extra snacks that are supposed to protect the sick child from hypoglycemia (a significant and dangerous drop in blood glucose levels), as well as eating something that he wants, sometimes even cookies.

It is possible to add several units of a fast-acting inspina analogue, which is especially important for children. Fast-acting analogues are absorbed after a few minutes, so they can be administered immediately before a meal (it is not necessary, as in the case of human inspina, to maintain a 30-45-minute interval between the injection and the start of the meal). Doses may also be adjusted as needed on an ad hoc basis.